Tag Archive for ‘Avastin’
Multi-Center NOSE Study
“Since my involvement with the HHT Foundation, the one area that has always been a top priority for members is better treatments of nosebleeds,” says Marianne Clancy, Executive Director. Now, after 2 years of careful design, the HHT Foundation is about to launch the largest epistaxis clinical study involving the North American Centers of Excellence.
Important News About Avastin in Treatment of Nosebleeds
Important News About Avastin in Treatment of Nosebleeds Dr. James Gossage HHT Foundation, Medical Director There is a lot of “buzz” about Avastin in the HHT community during the past year or two. Avastin is the trade name for bevacizumab. Bevacizumab is an antibody that can attach to a protein called vascular endothelial growth factor [...]
Myspace
Youtube
Twitter
Facebook